{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:23:49Z","timestamp":1775809429435,"version":"3.50.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Among multidrug-resistant organisms (MDROs), Vancomycin-resistant Enterococcus (VRE), and Carbapenem-resistant Enterobacteriaceae (CRE) have become major nosocomial pathogens that are endemic worldwide. If VRE\/CRE are present as colonizing organisms but do not act as pathogens, these organisms do not cause symptoms and do not require antibiotic use. However, once gastrointestinal colonization with VRE\/CRE occurs, it can persist for long periods and serve as a reservoir for transmission to other patients. Therefore, a breakthrough strategy to control the spread of MDRO colonization is needed. We herein introduce decolonization method, which is a comprehensive, multisystem, consecutive mechanical MDRO decolonization protocol that does not utilize antibiotics.<\/jats:p>\n            <jats:p>Our protocol included<\/jats:p>\n            <jats:p>These steps were repeated consecutively until the patient was released from quarantine. We conducted VRE\/CRE tests every week. Because our protocol was a comprehensive and multisystem decolonization protocol, the cooperation of patients and\/or caregivers was essential, and family support was important for patient care. Patients were divided into VRE and CRE groups and were subdivided into success and failure groups according to decolonization status.<\/jats:p>\n            <jats:p>Thirty-two patients with VRE or CRE colonization were enrolled, and our protocol was performed. A total of 20 patients (62.5%) were successfully decolonized after repeated protocols. Univariate analysis revealed that patients with younger age, higher body mass index (BMI), shorter period of MDRO isolation without trial, and higher functional status showed significantly enhanced success rates with our decolonization protocol.<\/jats:p>\n            <jats:p>This study presents the decolonization effects of a comprehensive, multisystem, mechanical decolonization protocol for VRE and CRE. Most importantly, our decolonization protocol does not use antibiotics and is thus not harmful. These results suggest an active decolonization trial to be performed as early as possible in patients with VRE or CRE colonization. This simple, easy-to-apply protocol can be used as 1 of the basic treatment options for MDROs infection or colonization, regardless of whether it requires antibiotic treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023686","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T13:47:06Z","timestamp":1611409626000},"page":"e23686","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Comprehensive, multisystem, mechanical decolonization of Vancomycin-Resistant Enterococcus and Carbapenem-Resistant Enterobacteriacease without the use of antibiotics"],"prefix":"10.1097","volume":"100","author":[{"given":"Eunseok","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6894-445X","authenticated-orcid":false,"given":"Sook Joung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangjee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinseok","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Soo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Seoul, Republic of Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-youn","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunwoo","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(20)30673-5","article-title":"COVID-19: towards controlling of a pandemic","volume":"395","author":"Bedford","year":"2020","journal-title":"Lancet (London, England)"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2334-14-514","article-title":"Decolonization of gastrointestinal carriage of vancomycin-resistant Enterococcus faecium: case series and review of literature","volume":"14","author":"Cheng","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2334-14-177","article-title":"Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review","volume":"14","author":"Shenoy","year":"2014","journal-title":"BMC Infect Dis"},{"key":"R4-20250504","first-page":"217","article-title":"Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management","volume":"8","author":"O\u2019Driscoll","year":"2015","journal-title":"Infect Drug Resist"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of Carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerging infectious diseases"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","article-title":"The rapid spread of carbapenem-resistant Enterobacteriaceae","volume":"29","author":"Potter","year":"2016","journal-title":"Drug Resist Updat"},{"key":"R7-20250504","first-page":"1704","article-title":"Gut microbiota modulation for multidrug-resistant organism decolonization","volume":"10","author":"Gargiullo","year":"2019","journal-title":"XXX"},{"issue":"(Suppl 3)","key":"R8-20250504","first-page":"iii13","article-title":"Clinical impact of vancomycin-resistant enterococci","volume":"51","author":"Patel","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/jac\/dkr204","article-title":"Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study","volume":"66","author":"Yoon","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1086\/323762","article-title":"Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of \u201cclearance\u201d","volume":"33","author":"Baden","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/502036","article-title":"Duration of colonization with vancomycin-resistant Enterococcus","volume":"23","author":"Byers","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"(Suppl 4)","key":"R12-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0213-005X(14)70173-9","article-title":"Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis","volume":"32","author":"Pano Pardo","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3201\/eid1106.041204","article-title":"Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex","volume":"11","author":"Willems","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/14787210.2016.1106940","article-title":"Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE)","volume":"14","author":"Goodman","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R15-20250504","first-page":"452","article-title":"Ecological effects of selective decontamination on resistant gram-negative","volume":"181","author":"Oostdijk","year":"2010","journal-title":"XXX"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-017-0291-z","article-title":"Economic burden of nosocomial infections caused by vancomycin-resistant enterococci","volume":"7","author":"Puchter","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOG.0000000000000596","article-title":"Carbapenemase-producing Enterobacteriaceae - once positive always positive?","volume":"36","author":"Vink","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5124\/jkma.2018.61.1.26","article-title":"Management of Multi-drug resistant organisms in healthcare settings","volume":"61","author":"Park","year":"2018","journal-title":"J korean Med Assoc"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0196-6553(95)90104-3","article-title":"Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)","volume":"23","year":"1995","journal-title":"Am J Infec Cont"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jiac.2018.01.001","article-title":"Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection, Focus on Enterococcus gallinarum and Enterococcus casseliflavus\/flavescens","volume":"24","author":"Monticelli","year":"2018","journal-title":"J Infect Chemother"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/cc13949","article-title":"Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?","volume":"18","author":"Yamamoto","year":"2014","journal-title":"Critical care (London, England)"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5694\/j.1326-5377.2007.tb00995.x","article-title":"Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled","volume":"186","author":"Manley","year":"2007","journal-title":"Med J Aust"},{"key":"R28-20250504","first-page":"487","article-title":"The bacteriostatic effect of Medilac-Vita on enteric pathogen and conditioned pathogen and their bacterial L form","volume":"26","author":"Zhong","year":"2006","journal-title":"Ganan Yixueyuan Xuebao"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-012-0313-0","article-title":"Mucosal immunology and probiotics","volume":"13","author":"Dongarr\u00e0","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.idc.2016.07.009","article-title":"Vancomycin-resistant enterococci: epidemiology, infection prevention, and control","volume":"30","author":"Reyes","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"R31-20250504","first-page":"533","article-title":"Effect of daily chlorhexidine bathing on hospital-acquired infection","volume":"368","author":"Climo","year":"2013","journal-title":"XXX"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/502196","article-title":"Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs","volume":"24","author":"Song","year":"2003","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:01:29Z","timestamp":1746342089000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023686","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"2020-06-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}